ICP Solar Technologies Inc. (ICPR.OB) Leaps to International Status with Letter of Intent
Vision is an elusive talent for many company managers. It is, in many instances, quite a bit easier to follow…
Blog
Volterra Semiconductor Corp. (VLTR) Announces Positive Third Quarter Earnings
Volterra Semiconductor Corporation (NASD: VLTR), a leading provider of high-performance analog and mixed-signal power management semiconductors, recently announced the company’s…
The Fight Zone, Inc. (TFZI.PK): An Investment Opportunity in the Mixed Martial Arts World
The Fight Zone, Inc. (TFZI.PK) is dedicated to developing and promoting the mixed martial arts (MMA) world and their athletes.…
Tri-Star Holdings, Inc. (TSHL.PK) Divests Amore TV, Appoints Three New Officers
Today, Tri-Star Holdings announced that it has divested Amore TV as part of its corporate restructuring strategy and vision of…
FDA Approves the Endologix, Inc. (ELGX) IntuiTrak™ Delivery System
Abdominal Aortic Aneurysms (AAA) is an aneurysm caused from a weakening of the wall of the aorta, the largest artery…
Elray Resources, Inc. (ELRA.OB) – Diving into the Zircon Sands of Indonesia
Founded by senior executives and geologists with experience in the major gold production companies, Elray Resources saw a niche for…
China Water and Drinks, Inc. (CWDK.OB) and Heckmann Corporation (HEK) Close Acquisitions
Bottled water continues to be a huge market worldwide. Back in May, China Water entered into a definitive merger agreement…
RXi Pharmaceuticals (RXII) Hires Dr. Anastasia Khvorova as its First Chief Scientific Officer
RXi Pharmaceuticals Corporation (NASDAQ: RXII) reported today that it has hired Dr. Anastasia Khvorova to fill the new post of…
Kidney Cancer May Meet its Match with Antigenics Inc.’s (AGEN) Marketing Application Submittal
Renal Cell Carcinoma is the most common type of kidney cancer. According to the International Agency for Research on Cancer,…
Monogram Biosciences, Inc. (MGRM) Presents Its VeraTagTM Assays at EORTC-NCI-AACR Symposium
Monogram Biosciences, Inc., a California based leader in molecular diagnostics for improving drug treatment of serious diseases, today announced presentations…